Sandra Percell
Novartis (Switzerland)(CH)GlaxoSmithKline (India)(IN)GlaxoSmithKline (United States)(US)Novartis (United States)(US)
Publications by Year
Research Areas
Bacterial Infections and Vaccines, Pneumonia and Respiratory Infections, Neonatal and Maternal Infections, Influenza Virus Research Studies, Sepsis Diagnosis and Treatment
Most-Cited Works
- → Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis(2003)953 cited
- → Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study(2001)252 cited
- → A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant(1999)248 cited
- → Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine(1999)106 cited
- → Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study(2015)48 cited
- → Antibody Persistence After Primary and Booster Doses of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents(2014)32 cited